Michael Ongele, MD
Anesthesiology · Washington
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 7 years
- Duke University School of Medicine, 2019
Offices
1 location · Medstar Medical Group II LLC · 3,726 clinicians in this group
Hospitals listed: Medstar Washington Hospital Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ongele’s office at (202) 877-7000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A183969 · Delinquent
Licence status: Delinquent · since 2023 · expires 2025-04-01 · Duke University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Medstar Washington Hospital CenterWashington, DCAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of MedStar Health, which runs 10 hospitals in 2 statesPatients rate it 2 of 5 · 62% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.71 (0.54 to 0.88), Jul 2022 – Jun 2024Better than the national rate — Postoperative acute kidney injury requiring dialysis rate: 0.68 (0 to 1.65) · 2,469 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 1.94 (0 to 4.79) · 2,589 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 1.71 (0 to 3.99) · 2,593 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.22, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.266, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.567, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.373, Oct 2024 – Sep 2025
See every measure and the patient survey for Medstar Washington Hospital Center
Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.71 (0.54 to 0.88) | Better | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.68 (0 to 1.65) · 2,469 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 1.94 (0 to 4.79) · 2,589 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 1.71 (0 to 3.99) · 2,593 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.22 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.266 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.567 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.29 (0.55 to 2.03) · 2,968 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 177.1 (151.44 to 202.76) · 435 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 551 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.3 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 381 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7 · 800 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.1 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.8 · 488 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,377 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 14,298 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.11 to 0.44) · 15,943 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.18 (2.89 to 5.47) · 5,921 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (1.12 to 3) · 5,366 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.54 (0.23 to 2.84) · 916 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.83 (0.5 to 1.15) · 13,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 79 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.066 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 628 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 1,305 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.8 · 635 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 4.7 · 1,052 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1.1 · 365 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.5 · 512 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.3) · 356 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (8.4 to 13.8) · 356 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 85 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 352 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 219 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.1 (10.9 to 18.2) · 1,079 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.4) · 956 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,420 patients answered, 14% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 60% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 61% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 62% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$24,139
Medicare paid this office $24,139 for 42 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of artery tube for blood sampling or infusion through skin | 27 | $995 | $37 |
| Injection of anesthetic agent and/or steroid into rib nerve | 11 | $824 | $75 |
| Ultrasonic guidance for blood vessel access | 20 | $234 | $12 |
Who their Medicare patients are
42 Original Medicare patients in 2024. Average age 73 · Women 48% · Health risk score 2.48. Sicker patients than 9 in 10 peers; the typical anesthesiology clinician is at 1.54.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Heart failure 64% · Diabetes 60% · Chronic kidney disease 60% · Atrial fibrillation 50% · Stroke 31%.
The office billed $158,258, Medicare allowed $30,297 and paid $24,139; for 146 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 19 Part D prescriptions in 2020. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$84 in 2025
| 2025 | 2 | 3 | None | $84 |
| 2024 | 1 | 1 | None | $25 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $59 | 2 payments
|
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $25 | 1 payment
|
See all 3 published payments
| Abbott Laboratories | Meals · 2025-12-24 | Thoratec Heartmate 3 Lvas Implant Kit | $25 |
| Abiomed | Meals · 2025-11-21 | None | $27 |
| Abiomed | Meals · 2025-07-16 | None | $32 |
See earlier years (2024)
2024: $25
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $25 | 1 payment
|
Professional record
- NPI
- 1710447057
- Licence
- CA A183969California A183969: Delinquent · expires 2025-04-01
- Trained
- Duke University School of Medicine, 2019 · 7 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207L00000X (207L00000X); Student in a training program (390200000X)
- Mailing address
- 512 San Benito Ave, Menlo Park, CA, 94025
- NPI first listed
- 2019-03-22
- NPI last updated
- 2024-01-31
- NPI record certified
- 2023-06-25
This is when the NPI record was last certified, not a medical board exam.